19 research outputs found

    Heat map and hierarchical clustering.

    No full text
    <p>Individual miRNA expression were calculated by R platform and heat map was computed and described using a function of heatmap.2 in gplots. It uses hierarchical clustering with Euclidean distance; Pearson Linear Correlation and Ward's method to generate the hierarchical tree <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0066086#pone.0066086-Ward1" target="_blank">[56]</a>. ANOVA was applied to extract differentially expressed miRNAs and adjustment of the p-value by multiple comparisons was performed by calculating FDR. Those miRNAs with FDR<0.1 were presented. The red indicates high level of miRNA expression and the blue shows low.</p

    Validation of deep sequencing results for selected miRNAs.

    No full text
    <p>We have registered 10 samples in each group listed on Table S3. The threshold cycle for each miRNA primer/probe set were normalized with spiked in cel-miR-39 primer/probe pair and compared to CH-C-5. Result for normally distributed continuous variables are given as means and compared between groups by Student's t-test. <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0066086#s2" target="_blank">Results</a> for non-normally distributed continuous variables are summarized as medians and were compared by Mann-Whitney U test. Statistical significance indicates by one asterisk (p<0.05) and two (p<0.01).</p

    Clinical data for patients enrolled in Illumina sequencing analysis.

    No full text
    a<p>We used the Scheuer score in PBC and fibrosis score of histological activity index (HAI) in CH-B and CH-C <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0066086#pone.0066086-Knodell1" target="_blank">[53]</a><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0066086#pone.0066086-Ludwig1" target="_blank">[54]</a><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0066086#pone.0066086-Scheuer1" target="_blank">[55]</a>.</p>b<p>URSO is the abbreviation for ursodeoxycholic acid, IFN for interferon and NA for nucleos(t)ide analogue.</p

    HCV Infection Enhances Th17 Commitment, Which Could Affect the Pathogenesis of Autoimmune Diseases

    No full text
    <div><p>Background</p><p>Various kinds of autoimmune diseases have been reported to have a significant relationship with persistent hepatitis c virus (HCV) infection and Th17 cells. Previously, our group reported that the existence of HCV in T lymphocytes could affect the development of CD4<sup>+</sup> helper T cells and their proliferation, in addition to the induction of immunoglobulin hyper-mutation.</p><p>Methods</p><p>Therefore, we analyzed the relationship between persistent infection of HCV and the mechanism of Th17 cell induction <i>ex vivo</i> and <i>in vitro</i>.</p><p>Results</p><p>The prevalence of autoimmune-related diseases in chronic hepatitis c patients (CH-C) was significantly higher than in other types of chronic hepatitis (hepatitis B and NASH). A significantly higher frequency of IL6 and TGF-β double-high patients was detected in CH-C than in other liver diseases. Moreover, these double-high patients had significantly higher positivity of anti-nuclear antibody, cryoglobulinemia, and lymphotropic HCV and higher amounts of IL1-β, IL21, IL23. In addition to the previously reported lymphotropic SB-HCV strain, we found a novel, genotype 1b lymphotropic HCV (Ly-HCV), by deep sequencing analysis. Lymphotropic-HCV replication could be detected in the lymphoid cells with various kinds of cytokine-conditions including IL1β, IL23, IL6 and TGF-β in vitro. Infection by HCV could significantly enhance the development of Th17 cells. The HCV protein responsible for inducing the Th17 cells was HCV-Core protein, which could enhance the STAT-3 signaling and up-regulate the expression of RORγt as a Th17 master gene.</p><p>Conclusion</p><p>Infection by lymphotropic HCV might enhance the Th17 development and contribute to understanding the pathogenesis of autoimmune-related diseases.</p></div

    The cytokine conditions affecting the positivity of ANA and Cryoglobulin, and Th17 development.

    No full text
    <p>A comparison of the amounts of IL6 and TGF-β among the CH-C, CH-B, NASH and healthy subjects is shown (A). The bar indicates the mean cytokine amounts. The frequency of TGF-β1 high, IL6 high, and TGF-β1 and IL6 double high patients among the 4 groups (CH-C, CH-B, NASH, and healthy subjects) is shown (B). The positive rate of ANA and Cryoglobulin in the double high CH-C patients (n = 9) and the other CH-C patients (n = 26) is shown(C). The IL6 and TGF-β1 mRNA expression of PBMCs in the double-high patients (n = 9) and other patients (n = 26) is shown in the bar graphs (D). The amounts of IL1β, IL17A, IL21 and IL23 in the serum were compared between double high CH-C patients (n = 9) and the other CH-C patients (n = 26) (E). The comparisons of serum cytokines before and after the Peg-interferon/Ribavirin treatment are shown (F). Serum samples were collected at just before the treatment and twelve month after the end of treatment. SVR indicates sustained virological treatment (n = 5).</p

    The relation between CH-C and the phenotype of autoimmune- diseases.

    No full text
    <p>The prevalence of these diseases in CH-C (n = 250) was significantly higher than in other chronic liver diseases (n = 98) (p = 0.0011) (A). The prevalence of these diseases and the positive rate of cryoglobulin, ANA (>40 times), ASMA (>20 times) and AMA (>20 times), and the amount of IgG (>2000mg/dl) are shown (B).</p
    corecore